SCHEMBL30440308

SCHEMBL30440308

CC(C)C(=O)CCC(C)(C)N(C)C(=O)OCc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
ABCB1 P08183 2/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
CTSL P07711 2/20 0.38
CTSB P07858 2/20 0.38
CTSS P25774 2/20 0.38
CTSK P43235 2/20 0.38
SIGMAR1 Q99720 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KMT2A Q03164 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
SLC15A1 P46059 1/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30440629 0.81 ALDH1A1 (0.41) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2
SCHEMBL22326382 0.79 ALDH1A1 (0.50) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2
SCHEMBL23944994 0.78 MBOAT4 (0.47) ALDH1A1MAPTHPGDSMN1; SMN2MAPK1
SCHEMBL23944461 0.77 ALDH1A1 (0.55) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2
SCHEMBL25901621 0.76 ALDH1A1 (0.53) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2
SCHEMBL11568741 0.76 ALDH1A1 (0.47) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2
SCHEMBL1285759 0.75 ALDH1A1 (0.51) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2
SCHEMBL8276259 0.74 ABCB1 (0.56) ALDH1A1ABCB1MAPTHPGDCTSL
SCHEMBL11568854 0.74 CTSS (0.45) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2
SCHEMBL22780788 0.74 ALDH1A1 (0.50) ALDH1A1ABCB1MAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12473295-B2 Substituted straight chain spiro derivatives JANSSEN PHARMACEUTICA NV (BE) 2025-11-18 US disclosed
US-20230142285-A1 SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473295-B2 Substituted straight chain spiro derivatives MLLT1, MEN1, MLLT3 ALDH1A1 2388/4885ABCB1 3281/4885MAPT 3402/4885
US-20230142285-A1 SUBSTITUTED STRAIGHT CHAIN SPIRO DERIVATIVES MLLT1, MEN1, MLLT3 ALDH1A1 2388/4885ABCB1 3281/4885MAPT 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.